Sample | Title | Value | Rank |
GSM958322 | U87-EV human glioblastoma xenograft - Control - 1 [HG-U133_Plus_2] | 5.8625 | 67 |
GSM958323 | U87-EV human glioblastoma xenograft - Control - 2 [HG-U133_Plus_2] | 5.94191 | 68 |
GSM958324 | U87-EV human glioblastoma xenograft - Control - 3 [HG-U133_Plus_2] | 5.89808 | 68 |
GSM958328 | U87-EV human glioblastoma xenograft - Bevacizumab treated - 1 [HG-U133_Plus_2] | 6.02615 | 68 |
GSM958329 | U87-EV human glioblastoma xenograft - Bevacizumab treated - 2 [HG-U133_Plus_2] | 5.80731 | 67 |
GSM958330 | U87-EV human glioblastoma xenograft - Bevacizumab treated - 3 [HG-U133_Plus_2] | 5.8973 | 68 |
GSM958325 | U87-EV human glioblastoma xenograft - dibenzazepine treated - 1 [HG-U133_Plus_2] | 5.82086 | 67 |
GSM958326 | U87-EV human glioblastoma xenograft - dibenzazepine treated - 2 [HG-U133_Plus_2] | 6.0915 | 68 |
GSM958327 | U87-EV human glioblastoma xenograft - dibenzazepine treated - 3 [HG-U133_Plus_2] | 5.82588 | 67 |